The epidemiology of hepatitis C virus in Egypt

A systematic review and data synthesis

Yousra A. Mohamoud, Ghina R. Mumtaz, Suzanne Riome, De Wolfe Miller, Laith Aburaddad

Research output: Contribution to journalArticle

188 Citations (Scopus)

Abstract

Background: Egypt has the highest prevalence of hepatitis C virus (HCV) in the world, estimated nationally at 14.7%. Our study's objective was to delineate the evidence on the epidemiology of HCV infection among the different population groups in Egypt, and to draw analytical inferences about the nature of HCV transmission in this country.Methods: We conducted a systematic review of all data on HCV prevalence and incidence in Egypt following PRISMA guidelines. The main sources of data included PubMed and Embase databases. We also used a multivariate regression model to infer the temporal trend of HCV prevalence among the general population and high risk population in Egypt.Results: We identified 150 relevant records, four of which were incidence studies. HCV incidence ranged from 0.8 to 6.8 per 1,000 person-years. Overall, HCV prevalence among pregnant women ranged between 5-15%, among blood donors between 5-25%, and among other general population groups between 0-40%. HCV prevalence among multi-transfused patients ranged between 10-55%, among dialysis patients between 50-90%, and among other high risk populations between 10% and 85%. HCV prevalence varied widely among other clinical populations and populations at intermediate risk. Risk factors appear to be parenteral anti-schistosomal therapy, injections, transfusions, and surgical procedures, among others. Results of our time trend analysis suggest that there is no evidence of a statistically significant decline in HCV prevalence over time in both the general population (p-value: 0.215) and high risk population (p-value: 0.426).Conclusions: Egypt is confronted with an HCV disease burden of historical proportions that distinguishes this nation from others. A massive HCV epidemic at the national level must have occurred with substantial transmission still ongoing today. HCV prevention in Egypt must become a national priority. Policymakers, and public health and medical care stakeholders need to introduce and implement further prevention measures targeting the routes of HCV transmission.

Original languageEnglish
Article number288
JournalBMC Infectious Diseases
Volume13
Issue number1
DOIs
Publication statusPublished - 24 Jun 2013
Externally publishedYes

Fingerprint

Egypt
Hepacivirus
Epidemiology
Population
Virus Diseases
Population Groups
Information Storage and Retrieval
Incidence
Blood Donors
PubMed
Pregnant Women
Dialysis

Keywords

  • Egypt
  • Epidemiology
  • Hepatitis C Virus
  • Incidence
  • Prevalence
  • Systematic Review

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

The epidemiology of hepatitis C virus in Egypt : A systematic review and data synthesis. / Mohamoud, Yousra A.; Mumtaz, Ghina R.; Riome, Suzanne; Miller, De Wolfe; Aburaddad, Laith.

In: BMC Infectious Diseases, Vol. 13, No. 1, 288, 24.06.2013.

Research output: Contribution to journalArticle

Mohamoud, Yousra A. ; Mumtaz, Ghina R. ; Riome, Suzanne ; Miller, De Wolfe ; Aburaddad, Laith. / The epidemiology of hepatitis C virus in Egypt : A systematic review and data synthesis. In: BMC Infectious Diseases. 2013 ; Vol. 13, No. 1.
@article{f801bc6913ce4b7ba9f0bfb3b0e08367,
title = "The epidemiology of hepatitis C virus in Egypt: A systematic review and data synthesis",
abstract = "Background: Egypt has the highest prevalence of hepatitis C virus (HCV) in the world, estimated nationally at 14.7{\%}. Our study's objective was to delineate the evidence on the epidemiology of HCV infection among the different population groups in Egypt, and to draw analytical inferences about the nature of HCV transmission in this country.Methods: We conducted a systematic review of all data on HCV prevalence and incidence in Egypt following PRISMA guidelines. The main sources of data included PubMed and Embase databases. We also used a multivariate regression model to infer the temporal trend of HCV prevalence among the general population and high risk population in Egypt.Results: We identified 150 relevant records, four of which were incidence studies. HCV incidence ranged from 0.8 to 6.8 per 1,000 person-years. Overall, HCV prevalence among pregnant women ranged between 5-15{\%}, among blood donors between 5-25{\%}, and among other general population groups between 0-40{\%}. HCV prevalence among multi-transfused patients ranged between 10-55{\%}, among dialysis patients between 50-90{\%}, and among other high risk populations between 10{\%} and 85{\%}. HCV prevalence varied widely among other clinical populations and populations at intermediate risk. Risk factors appear to be parenteral anti-schistosomal therapy, injections, transfusions, and surgical procedures, among others. Results of our time trend analysis suggest that there is no evidence of a statistically significant decline in HCV prevalence over time in both the general population (p-value: 0.215) and high risk population (p-value: 0.426).Conclusions: Egypt is confronted with an HCV disease burden of historical proportions that distinguishes this nation from others. A massive HCV epidemic at the national level must have occurred with substantial transmission still ongoing today. HCV prevention in Egypt must become a national priority. Policymakers, and public health and medical care stakeholders need to introduce and implement further prevention measures targeting the routes of HCV transmission.",
keywords = "Egypt, Epidemiology, Hepatitis C Virus, Incidence, Prevalence, Systematic Review",
author = "Mohamoud, {Yousra A.} and Mumtaz, {Ghina R.} and Suzanne Riome and Miller, {De Wolfe} and Laith Aburaddad",
year = "2013",
month = "6",
day = "24",
doi = "10.1186/1471-2334-13-288",
language = "English",
volume = "13",
journal = "BMC Infectious Diseases",
issn = "1471-2334",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - The epidemiology of hepatitis C virus in Egypt

T2 - A systematic review and data synthesis

AU - Mohamoud, Yousra A.

AU - Mumtaz, Ghina R.

AU - Riome, Suzanne

AU - Miller, De Wolfe

AU - Aburaddad, Laith

PY - 2013/6/24

Y1 - 2013/6/24

N2 - Background: Egypt has the highest prevalence of hepatitis C virus (HCV) in the world, estimated nationally at 14.7%. Our study's objective was to delineate the evidence on the epidemiology of HCV infection among the different population groups in Egypt, and to draw analytical inferences about the nature of HCV transmission in this country.Methods: We conducted a systematic review of all data on HCV prevalence and incidence in Egypt following PRISMA guidelines. The main sources of data included PubMed and Embase databases. We also used a multivariate regression model to infer the temporal trend of HCV prevalence among the general population and high risk population in Egypt.Results: We identified 150 relevant records, four of which were incidence studies. HCV incidence ranged from 0.8 to 6.8 per 1,000 person-years. Overall, HCV prevalence among pregnant women ranged between 5-15%, among blood donors between 5-25%, and among other general population groups between 0-40%. HCV prevalence among multi-transfused patients ranged between 10-55%, among dialysis patients between 50-90%, and among other high risk populations between 10% and 85%. HCV prevalence varied widely among other clinical populations and populations at intermediate risk. Risk factors appear to be parenteral anti-schistosomal therapy, injections, transfusions, and surgical procedures, among others. Results of our time trend analysis suggest that there is no evidence of a statistically significant decline in HCV prevalence over time in both the general population (p-value: 0.215) and high risk population (p-value: 0.426).Conclusions: Egypt is confronted with an HCV disease burden of historical proportions that distinguishes this nation from others. A massive HCV epidemic at the national level must have occurred with substantial transmission still ongoing today. HCV prevention in Egypt must become a national priority. Policymakers, and public health and medical care stakeholders need to introduce and implement further prevention measures targeting the routes of HCV transmission.

AB - Background: Egypt has the highest prevalence of hepatitis C virus (HCV) in the world, estimated nationally at 14.7%. Our study's objective was to delineate the evidence on the epidemiology of HCV infection among the different population groups in Egypt, and to draw analytical inferences about the nature of HCV transmission in this country.Methods: We conducted a systematic review of all data on HCV prevalence and incidence in Egypt following PRISMA guidelines. The main sources of data included PubMed and Embase databases. We also used a multivariate regression model to infer the temporal trend of HCV prevalence among the general population and high risk population in Egypt.Results: We identified 150 relevant records, four of which were incidence studies. HCV incidence ranged from 0.8 to 6.8 per 1,000 person-years. Overall, HCV prevalence among pregnant women ranged between 5-15%, among blood donors between 5-25%, and among other general population groups between 0-40%. HCV prevalence among multi-transfused patients ranged between 10-55%, among dialysis patients between 50-90%, and among other high risk populations between 10% and 85%. HCV prevalence varied widely among other clinical populations and populations at intermediate risk. Risk factors appear to be parenteral anti-schistosomal therapy, injections, transfusions, and surgical procedures, among others. Results of our time trend analysis suggest that there is no evidence of a statistically significant decline in HCV prevalence over time in both the general population (p-value: 0.215) and high risk population (p-value: 0.426).Conclusions: Egypt is confronted with an HCV disease burden of historical proportions that distinguishes this nation from others. A massive HCV epidemic at the national level must have occurred with substantial transmission still ongoing today. HCV prevention in Egypt must become a national priority. Policymakers, and public health and medical care stakeholders need to introduce and implement further prevention measures targeting the routes of HCV transmission.

KW - Egypt

KW - Epidemiology

KW - Hepatitis C Virus

KW - Incidence

KW - Prevalence

KW - Systematic Review

UR - http://www.scopus.com/inward/record.url?scp=84879246308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879246308&partnerID=8YFLogxK

U2 - 10.1186/1471-2334-13-288

DO - 10.1186/1471-2334-13-288

M3 - Article

VL - 13

JO - BMC Infectious Diseases

JF - BMC Infectious Diseases

SN - 1471-2334

IS - 1

M1 - 288

ER -